drugset / Trial / NCT04029090
A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects
RandomizedCrossoverDouble-blindOther
Summary
To evaluate the effect of MCI-186 on the QT interval corrected for heart rate using Fridericia's formula (QTcF)
Timeline
- Start
- 2018-09-18
- Primary completion
- 2018-10-20
- Completion
- 2018-10-23
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Edaravone | Unknown | 60 mg | Intravenous |
| Subject | Edaravone | Unknown | 300 mg | Intravenous |
Indications
No indication recorded.